Fundraising Fox
Ostealtx
1 known investors
Find your way into Ostealtx
Sign up to see every warm intro you have to Ostealtx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ostealtx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Osteal Therapeutics is a clinical-stage pharmaceutical company developing novel treatments for orthopedic infections, particularly periprosthetic joint infections. Its lead product, NEXCHANGE KIT, is a drug-device combination designed for localized antibiotic delivery to infected joint prostheses.
Founders & leadership
BD
Brian de Beaubien, MDCo-Founder & Chief Medical Officer
DT
David ThompsonChairman & CEODavid Thompson is a healthcare business leader with over 25 years of experience in medical devices, digital health, and diagnostics across organizations of varying sizes. He has led product development, commercial strategy, and go-to-market execution in areas including orthopedics, rare disease therapeutics, and combination products.
Investors · 1
Frequently asked questions
- What does Ostealtx do?
- Osteal Therapeutics is a clinical-stage pharmaceutical company developing novel treatments for orthopedic infections, particularly periprosthetic joint infections. Its lead product, NEXCHANGE KIT, is a drug-device combination designed for localized antibiotic delivery to infected joint prostheses.
- Who founded Ostealtx?
- Ostealtx was founded by Brian de Beaubien, MD.
- Who are Ostealtx's investors?
- Ostealtx's investors include HM Venture Partners.